Display search results for ** instead (41 products)
06 Jun 2018  |  Global
31 May 2018  |  Global
Technology Companies to Action--Novel Selective Inhibitors Addressing Neurologic and Endocrine System Diseases
30 May 2018  |  Global
18 Dec 2017  |  Global
Non-Invasive Prenatal Testing and Carrier Screening are the Key Segments Triggering Growth Across the Market
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
16 Mar 2017  |  Global
Growth, Innovation and Leadership (GIL) Index for Emerging Markets
The opening up of emerging markets to global capital, technology, and talent over the past two decades has fundamentally changed their economic and business environment. Rapid emerging market economic growth has helped lift millions out of poverty and expand the middle class, creating new markets for consumer products and services. In addition a la...
19 Jan 2017  |  Global
16 Nov 2016  |  Global
Assessing the Innovations in Orthopedic Devices and Procedure Improvement Solutions that are set to Transform the Industry
The insight analyzes the innovations expected to play a major role in shaping the global orthopedic devices industry over the next few years. The demand for patient-specific implantation/surgeries is rising, along with the demand for better procedural efficiencies. This is becoming a driver for the emergence of new technologies. Therapies and proce...
29 Sep 2016  |  Global
08 Sep 2016  |  Global
Big Data Initiatives Targeted at Health Prediction and Precision
The healthcare industry has been a laggard in Big Data adoption as compared to other verticals and continues to battle challenges around interoperability, budget constraints, and insufficient strategic planning and change management. However, the intent to leverage the power of Big Data is evident across all industry stakeholders, including governm...
30 Jun 2016  |  Global
Immunoglobulin (Ig) therapies are among the oldest therapeutic moieties employed in a broad range of pathological conditions. Immunoglobulin G (IgG) holds the highest share (44%) in the global blood plasma market, with a revenue of $9.24 billion. Currently, the global Ig market is dominated by three major companies, holding about 85% of the total m...